TDOC - Teladoc Health, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue233,279123,15777,38443,528
Cost of Revenue61,62331,97121,0419,929
Gross Profit171,65691,18656,34333,599
Operating Expenses
Research Development34,45921,81514,2107,573
Selling General and Administrative176,913113,64889,27338,231
Non Recurring----
Others----
Total Operating Expenses292,090175,704129,38758,053
Operating Income or Loss-58,811-52,547-52,003-14,525
Income from Continuing Operations
Total Other Income/Expenses Net-48,196-21,159-5,981-2,124
Earnings Before Interest and Taxes-58,811-52,547-52,003-14,525
Interest Expense-17,491-2,588-2,199-1,499
Income Before Tax-107,007-73,706-57,984-16,649
Income Tax Expense-22551036388
Minority Interest----
Net Income From Continuing Ops-106,782-74,216-58,020-17,037
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-106,782-74,216-58,020-17,037
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-106,782-74,216-58,020-20,125